HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 436 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,382,035 | -15.4% | 11,948 | -24.8% | 0.01% | 0.0% |
Q2 2023 | $1,634,034 | -8.9% | 15,890 | -3.4% | 0.01% | -14.3% |
Q1 2023 | $1,794,449 | -71.7% | 16,444 | -87.7% | 0.01% | -46.2% |
Q4 2022 | $6,350,733 | +380.8% | 133,911 | +527.4% | 0.01% | +116.7% |
Q3 2022 | $1,321,000 | -43.8% | 21,344 | -51.8% | 0.01% | -45.5% |
Q2 2022 | $2,350,000 | -28.5% | 44,313 | +41.9% | 0.01% | -26.7% |
Q1 2022 | $3,285,000 | +2.8% | 31,221 | +5.3% | 0.02% | +15.4% |
Q4 2021 | $3,194,000 | -2.9% | 29,644 | -1.3% | 0.01% | -13.3% |
Q3 2021 | $3,291,000 | +12.1% | 30,035 | -4.1% | 0.02% | +15.4% |
Q2 2021 | $2,935,000 | +1.7% | 31,329 | -0.0% | 0.01% | +8.3% |
Q1 2021 | $2,885,000 | +368.3% | 31,342 | +271.6% | 0.01% | +300.0% |
Q4 2020 | $616,000 | -0.6% | 8,434 | +5.7% | 0.00% | 0.0% |
Q3 2020 | $620,000 | +87.3% | 7,977 | +33.7% | 0.00% | +50.0% |
Q2 2020 | $331,000 | +54.0% | 5,965 | +0.5% | 0.00% | +100.0% |
Q4 2019 | $215,000 | – | 5,935 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |